Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Jan 2023 for Pear Therapeutics, Inc., €9,064.
Filing timeline
BuySaleErin K. Brenner
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Erin K. Brenner: trading record in brief
Erin K. Brenner, listed as senior executive, appears in our data through filings on Pear Therapeutics, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 25 May 2022 to 20 January 2023.
The open-market record consists of 1 sale worth €9,064, with no purchase. Other entries cover 3 option exercises. Since January 2023: no purchases and 1 sale on the market.
On 24 January 2023 came the latest disclosure, an open-market sale for €9,064 in Pear Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Erin K. Brenner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
8,690 shares@ US$1.1324.3% of flowClass A Common StockSEC:0001062993-23-001327:0
22,000 shares0Common StockSEC:0001062993-23-001046:0
15,000 shares@ US$1.0038.1% of flowCommon StockSEC:0001062993-22-023633:0
15,000 shares@ US$1.0037.6% of flowCommon StockSEC:0001062993-22-013687:0
4 of 4 declarations
